Hongkou Capital
Hongkou Capital is a private equity firm established in 2020 and located in New York, New York. The firm specializes in investment strategies that include buyouts and growth capital. Hongkou Capital focuses its investments on sectors such as business-to-consumer, electronics, and cleantech. As a Registered Investment Adviser, the firm is committed to managing investments in a way that aligns with regulatory standards and client interests.
2 past transactions
Day Zero Diagnostics
Venture Round in 2022
Day Zero Diagnostics develops sequencing-based diagnostics for infectious diseases. Its proprietary technologies enable rapid identification of bacterial species and antibiotic resistance profiles from clinical samples, targeting bloodstream infections and sepsis initially. The company aims to improve patient outcomes by providing comprehensive diagnoses within hours instead of days.
Amionx
Series B in 2021
Amionx develops Safe Core technology that functions as a circuit breaker within lithium‑ion batteries, preventing fires and explosions without compromising performance. The system protects against overcharge, internal short circuits, and external heat across all battery chemistries, including solid‑state designs. By integrating safety at the core of the battery, Amionx enables original equipment manufacturers to reduce battery‑related accidents and enhance overall reliability.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.